Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients
| Published in: | HemaSphere |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000829 |
